GALECTIN THERAPEUTICS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Galectin Therapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Galectin Therapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$11.2M, a 7.6% decline year-over-year.
  • Galectin Therapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$45.1M, a 8.09% decline year-over-year.
  • Galectin Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$41.1M, a 5.91% decline from 2022.
  • Galectin Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$38.8M, a 27% decline from 2021.
  • Galectin Therapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$30.5M, a 30.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$45.1M -$11.2M -$792K -7.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$44.3M -$12.4M -$3.26M -35.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$41M -$11.5M +$38K +0.33% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$41.1M -$10M +$637K +5.99% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$41.7M -$10.4M -$1.83M -21.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$39.9M -$9.11M +$499K +5.19% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$40.4M -$11.5M -$1.6M -16.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$38.8M -$10.6M -$3.41M -47.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$35.4M -$8.6M -$77K -0.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$35.3M -$9.61M -$1.16M -13.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$34.1M -$9.93M -$3.59M -56.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$30.5M -$7.22M +$632K +8.05% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$31.2M -$8.52M -$2.58M -43.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$28.6M -$8.45M -$2.34M -38.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$26.2M -$6.34M -$2.78M -78.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$23.5M -$7.85M -$2.72M -52.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$20.8M -$5.94M -$3.16M -113% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$17.6M -$6.11M -$3.12M -104% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$14.5M -$3.56M -$1.18M -49.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$13.3M -$5.14M -$2.09M -68.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$11.2M -$2.78M -$32K -1.16% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$11.2M -$3M +$842K +21.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$12M -$2.38M +$1.88M +44.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$13.9M -$3.05M -$668K -28% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$13.2M -$2.75M +$1.66M +37.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$14.9M -$3.84M +$668K +14.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$15.6M -$4.26M +$679K +13.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$16.2M -$2.38M +$2.21M +48.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$18.4M -$4.41M +$118K +2.61% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$18.6M -$4.51M +$1.01M +18.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$19.6M -$4.94M +$1.86M +27.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$21.4M -$4.59M +$80K +1.71% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$21.5M -$4.53M +$1.36M +23.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$22.9M -$5.52M -$876K -18.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$22M -$6.8M -$1.97M -40.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$20M -$4.67M -$940K -25.2% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-15
Q3 2015 -$19.1M -$5.89M -$2.37M -67.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$16.7M -$4.64M -$1.21M -35.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$15.5M -$4.83M +$284K +5.56% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$15.8M -$3.73M -$932K -33.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$14.9M -$3.52M +$24K +0.68% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$14.9M -$3.43M -$885K -34.8% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$14M -$5.11M -$1.91M -59.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$12.1M -$2.8M -$423K -17.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-18
Q3 2013 -$11.7M -$3.54M -$853K -31.7% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-18
Q2 2013 -$10.8M -$2.54M +$116K +4.36% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-18
Q1 2013 -$10.9M -$3.2M -$1.25M -64.3% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-18
Q4 2012 -$9.68M -$2.38M +$992K +29.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-18
Q3 2012 -$10.7M -$2.69M -$661K -32.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$10M -$2.66M +$467K +14.9% Mar 29, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$10.5M -$1.95M +$442K +18.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$10.9M -$3.37M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-29
Q3 2011 -$2.03M -$919K -82.9% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$3.13M -$1.47M -89.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-10
Q1 2011 -$2.39M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$1.11M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 -$1.65M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.